Overview and Scope
Intravenous solutions are sterile liquids administered directly into a patient's bloodstream, typically for hydration, medication delivery, or nutrient supplementation. They are used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is impossible.
Sizing and Forecast
The intravenous solutions market size has grown strongly in recent years. It will grow from $12.9 billion in 2023 to $14 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rise in surgical procedures, growing prevalence of chronic diseases, expansion of home healthcare, stringent regulations ensuring product safety, increased focus on patient hydration, global emergency preparedness initiatives..
The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $18.95 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to population growth and aging, increasing surgical interventions, rising incidence of infectious diseases, telemedicine and remote patient monitoring, focus on preventive healthcare, global health security investments, patient-centric care trends.. Major trends in the forecast period include increased demand for parenteral nutrition solutions, rise in adoption of pre-mixed iv solutions, expansion of home infusion therapies, introduction of electrolyte-balanced solutions, introduction of novel drug additives and adjuncts, integration of smart iv systems for monitoring. .
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
Segmentation & Regional Insights
The intravenous solutions market covered in this report is segmented –
1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings
North America was the largest region in the intravenous solutions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cancer is expected to propel the growth of the intravenous solutions market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the ability to invade surrounding tissues and spread to other parts of the body. Intravenous solutions are commonly used in cancer treatment to deliver chemotherapy drugs and maintain hydration during therapy. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, around 1.9 million new cancer cases are expected to be diagnosed in the US, an increase from 1.8 million new cancer cases diagnosed in 2020. Further, in the US, 609,820 cancer-related deaths are anticipated in 2023, an increase from 606,520 in 2020. Therefore, the increasing prevalence of cancer is driving the growth of the intravenous solutions market.
Key Industry Players
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.</b
The intravenous solutions market report table of contents includes:
1. Executive Summary
2. Intravenous Solutions Market Characteristics
3. Intravenous Solutions Market Trends And Strategies
4. Intravenous Solutions Market - Macro Economic Scenario
5. Global Intravenous Solutions Market Size and Growth
.
.
.
32. Global Intravenous Solutions Market Competitive Benchmarking
33. Global Intravenous Solutions Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intravenous Solutions Market
35. Intravenous Solutions Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
